This conference builds on the successful conference held in 2011 and will highlight novel laboratory approaches, innovative pre-clinical science and the latest clinical trial results.

The aim is to discuss and advance our understanding of the aetiology, diagnosis and treatment of this challenging disease.

The 3 day programme covers all aspects of triple negative disease with invited plenary speakers and proffered abstracts presented as short talks or posters.

We aim to create a workshop atmosphere with ample opportunity for discussion and sharing expertise across disciplines.

The Conference has been awarded 15 category 1 (external) CPD credits by the Federation of the Royal Colleges of Physicians of the United Kingdom.